Jonathan D Campbell1, Marissa Brooks1, Patrick Hosokawa1, June Robinson1, Lin Song1, James Krieger1. 1. Jonathan D. Campbell is with the Pharmaceutical Outcomes Research Graduate Program, Center for Pharmaceutical Outcomes Research, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Anschutz Medical Campus, Department of Clinical Pharmacy, Aurora. Marissa Brooks is with Service Employees International Union NW Health Benefits Trust, Seattle, WA. Patrick Hosokawa is with Colorado Health Outcomes, University of Colorado, Aurora. June Robinson, Lin Song, and James Krieger were with Public Health - Seattle & King County, Seattle, WA.
Abstract
OBJECTIVES: We sought to estimate the return on investment of a streamlined version of an evidence-based community health worker (CHW) asthma home visit program. METHODS: We used a randomized parallel group trial of home visits by CHWs to Medicaid-enrolled children with uncontrolled asthma versus usual care. RESULTS: A total of 373 participants enrolled in the study (182 in the intervention group and 191 in the control group, of whom 154 and 179, respectively, completed the study). The intervention group had greater improvements in asthma symptom-free days (2.10 days more over 2 weeks; 95% CI = 1.17, 3.05; P < .001) and caretakers' quality of life (0.43 units more; 95% CI = 0.20, 0.66; P < .001) and a larger reduction in urgent health care utilization events (1.31 events fewer over 12 months; 95% CI = -2.10, -0.52; P = .001). The intervention arm compared with the control arm saved $1340.92 for the $707.04 additional costs invested for the average participant. The return on investment was 1.90. CONCLUSIONS: A streamlined CHW asthma home visit program for children with uncontrolled asthma improved health outcomes and yielded a return on investment of 1.90.
RCT Entities:
OBJECTIVES: We sought to estimate the return on investment of a streamlined version of an evidence-based community health worker (CHW) asthma home visit program. METHODS: We used a randomized parallel group trial of home visits by CHWs to Medicaid-enrolled children with uncontrolled asthma versus usual care. RESULTS: A total of 373 participants enrolled in the study (182 in the intervention group and 191 in the control group, of whom 154 and 179, respectively, completed the study). The intervention group had greater improvements in asthma symptom-free days (2.10 days more over 2 weeks; 95% CI = 1.17, 3.05; P < .001) and caretakers' quality of life (0.43 units more; 95% CI = 0.20, 0.66; P < .001) and a larger reduction in urgent health care utilization events (1.31 events fewer over 12 months; 95% CI = -2.10, -0.52; P = .001). The intervention arm compared with the control arm saved $1340.92 for the $707.04 additional costs invested for the average participant. The return on investment was 1.90. CONCLUSIONS: A streamlined CHW asthma home visit program for children with uncontrolled asthma improved health outcomes and yielded a return on investment of 1.90.
Authors: Deidre D Crocker; Stella Kinyota; Gema G Dumitru; Colin B Ligon; Elizabeth J Herman; Jill M Ferdinands; David P Hopkins; Briana M Lawrence; Theresa A Sipe Journal: Am J Prev Med Date: 2011-08 Impact factor: 5.043
Authors: Wayne J Morgan; Ellen F Crain; Rebecca S Gruchalla; George T O'Connor; Meyer Kattan; Richard Evans; James Stout; George Malindzak; Ernestine Smartt; Marshall Plaut; Michelle Walter; Benjamin Vaughn; Herman Mitchell Journal: N Engl J Med Date: 2004-09-09 Impact factor: 91.245
Authors: Andrew F Beck; Alicia J Cohen; Jeffrey D Colvin; Caroline M Fichtenberg; Eric W Fleegler; Arvin Garg; Laura M Gottlieb; Matthew S Pantell; Megan T Sandel; Adam Schickedanz; Robert S Kahn Journal: Pediatr Res Date: 2018-05-23 Impact factor: 3.756
Authors: Molly A Martin; Valerie G Press; Kim Erwin; Helen Margellos-Anast; Stacy Ignoffo; Kate Sheridan McMahon; Giselle Mosnaim; Jessica Ramsay; S Margaret Paik Journal: J Asthma Date: 2017-07-18 Impact factor: 2.515
Authors: Jerry A Krishnan; Molly A Martin; Cortland Lohff; Giselle S Mosnaim; Helen Margellos-Anast; Julie A DeLisa; Kate McMahon; Kim Erwin; Leslie S Zun; Michael L Berbaum; Michael McDermott; Nina E Bracken; Rajesh Kumar; S Margaret Paik; Sharmilee M Nyenhuis; Stacy Ignoffo; Valerie G Press; Zachary E Pittsenbarger; Trevonne M Thompson Journal: Contemp Clin Trials Date: 2017-03-31 Impact factor: 2.226
Authors: Molly A Martin; Melissa Gutierrez Kapheim; Kim Erwin; Stacy Ignoffo; Kate McMahon; Amy OʼRourke; Lynn B Gerald; Meredith Barrett; Valerie G Press; Houshang Darabi; Jerry A Krishnan Journal: Fam Community Health Date: 2018 Jul/Sep